Related Experiment Video
Updated: Jun 30, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Prostate cancer: news in 2008]
1Service d'Urologie, INSERM 841 EQ 07, Hôpital Henri Mondor, 51 av du Maréchal De Lattre de Tassigny, 94010 Créteil, France. laurent.salomon@hmn.ap-hop-paris.fr
Abstract:
In 2007, prostate cancer was the subject of a large number of communications in international conferences. The most innovating studies that are likely to modify patient management were selected. The topics included cancer detection, active surveillance, surgery and treatment of urinary incontinence after prostatectomy, radiotherapy, and high-intensity focalized ultrasound (HIFU). Current hormone treatment modalities as well as the new therapies for hormone-resistant prostate cancer management were also evaluated in detail.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

